Health Canada
Symbol of the Government of Canada
Drugs and Health Products

Natural Health Products Ingredients Database

WHAT'S NEW

What's New is a listing of modifications to the NHPID since the last update. This page was most recently revised on July 05, 2017.

ANNOUNCEMENTS

The updates to the NHPID listed below apply to the most recent version of the ePLA (electronic Product Licence Application). All new electronic submissions of a Product Licence Application must use the latest version of the e-PLA, namely version 2.3.1, which is available for downloading from e-PLA 2.3.1


New Ingredients

In this update, the following non-homeopathic ingredients were added.

NHPID Name:
Polystyrene/Hydrogenated Polyisopentene Copolymer

Role:
Non-medicinal


NHPID Name:
Pomegranate protein

Role:
Medicinal


NHPID Name:
Garlic Flavour

Role:
Non-medicinal


NHPID Name:
Strawberry Banana Flavour

Role:
Non-medicinal


NHPID Name:
Stearyl Caprylate

Role:
Non-medicinal


NHPID Name:
Stearyl Caprylate

Role:
Non-medicinal


NHPID Name:
Monarda Didyma Leaf

Role:
Non-medicinal


NHPID Name:
Garlic Flavour

Role:
Non-medicinal


Removed Ingredients

In this update, the following non-homeopathic ingredients were removed.

No Changes.


Revised NHPID Names

In this update, the following non-homeopathic ingredients had their NHPID name revised.

No Changes.


Revised Proper and Common Names

In this update, the following non-homeopathic ingredients had their common or proper names revised.

No Changes.


New Roles

In this update, the roles of the following non-homeopathic ingredients were changed.

No Changes.


Revised Restrictions

In this update, the following non-homeopathic ingredients underwent a modification related to their restrictions.

NHPID Name:
Montan wax

New Route(s) of Adminstration added:
Topical


NHPID Name:
Montan wax

New Restriction Reference added:
CIR


NHPID Name:
D-Mannose

New Route(s) of Adminstration added:
Topical


NHPID Name:
D-Mannose

New Restriction Reference added:
KIBBEO


NHPID Name:
Bilberry Fruit Juice Concentrate

New Route(s) of Adminstration added:
Oral


NHPID Name:
Bilberry Fruit Juice Concentrate

New Route(s) of Adminstration added:
Topical


Other Ingredient Modifications

In this update, the following non-homeopathic ingredients underwent a modification different from those listed above, such as new source material, new preparation type, or new sub-ingredient relationship, etc.

NHPID Name:
Schizonepetae Spica

New Method(s) of Preparation added:
Decoction


NHPID Name:
Schizonepetae Spica

New Method(s) of Preparation added:
Decoction concentrate


NHPID Name:
D-Mannose

New NMI Purpose(s):
Humectant


NHPID Name:
D-Mannose

New NMI Purpose(s):
Skin-Conditioning Agent - Humectant


NHPID Name:
Apple Juice Concentrate

New NMI Purpose(s):
Colour Additive


NHPID Name:
D&C Red No. 27 Aluminum Lake

Toxicity Restriction changed:
Provisional tolerable weekly intake (PTWI) of 2 mg/kg body weight as aluminium from all sources. (WHO_JECFA_ALUMINIUM_2011)


NHPID Name:
D&C Yellow No. 10 Aluminum Lake

Toxicity Restriction changed:
Provisional tolerable weekly intake (PTWI) of 2 mg/kg body weight as aluminium from all sources. (WHO_JECFA_ALUMINIUM_2011)


NHPID Name:
FD&C Blue No. 1 Aluminum Lake

Toxicity Restriction changed:
Provisional tolerable weekly intake (PTWI) of 2 mg/kg body weight as aluminium from all sources. (WHO_JECFA_ALUMINIUM_2011)


NHPID Name:
FD&C Blue No. 2 Aluminum Lake

Toxicity Restriction changed:
Provisional tolerable weekly intake (PTWI) of 2 mg/kg body weight as aluminium from all sources. (WHO_JECFA_ALUMINIUM_2011)


NHPID Name:
FD&C Red No. 3 Aluminum Lake

Toxicity Restriction changed:
Provisional tolerable weekly intake (PTWI) of 2 mg/kg body weight as aluminium from all sources. (WHO_JECFA_ALUMINIUM_2011)


NHPID Name:
FD&C Red No. 40 Aluminum Lake

Toxicity Restriction changed:
Provisional tolerable weekly intake (PTWI) of 2 mg/kg body weight as aluminium from all sources. (WHO_JECFA_ALUMINIUM_2011)


NHPID Name:
FD&C Yellow No. 5 Aluminum Lake

Toxicity Restriction changed:
Provisional tolerable weekly intake (PTWI) of 2 mg/kg body weight as aluminium from all sources. (WHO_JECFA_ALUMINIUM_2011)


NHPID Name:
FD&C Yellow No. 6 Aluminum Lake

Toxicity Restriction changed:
Provisional tolerable weekly intake (PTWI) of 2 mg/kg body weight as aluminium from all sources. (WHO_JECFA_ALUMINIUM_2011)


NHPID Name:
Citric acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
Citric acid monohydrate

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
Glycolic Acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
D-Lactic acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
DL-Lactic acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
L-Lactic acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
DL-Malic acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
D-Malic acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
L-Malic acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
Dl-Mandelic acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
DL-Tartaric acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
D-Tartaric acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


NHPID Name:
L-Tartaric acid

Additional Details changed:
The presence of this ingredient on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potentially significant safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in topical natural health products, unless additional evidence for safety is submitted. For products containing 3 - 10% total alpha hydroxy acids (AHAs) and a pH equal to or greater than 3.5, risk statements are required. For products containing over 10% total AHAs and/or a pH between 3.0 and 3.5, evidence of safety must be provided to Health Canada. Reference: https://www.canada.ca/en/health-canada/services/consumer-product-safety/... AND http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=skin_peau&lang=eng


Monograph Modifications

In this update, the following single ingredient or product monographs were added or modified.

No Changes.


AbLS Modifications

In this update, the following abbreviated labelling standards were added or modified.

No Changes.


Controlled Vocabulary Modifications

In this update, the following controlled vocabulary (dosage forms, methods of preparation, quality test methods, etc) were added or modified.

No Changes.


Homeopathic Ingredient Modifications

In this update, the following homeopathic ingredients were added or modified.

No Changes.


PREVIOUS WHAT'S NEW